닥터빌 커뮤니티
컨퍼런스 상세안내
28th International Symposium of Yonsei Song-Dang Institute for Cancer Research
신청기간: 2023년 07월 10일 (월) ~ 2023년 11월 03일 (금)
진행기간: 2023년 11월 03일 (금)
주최: 연세송당암연구센터
Program
| TIME | SUBJECT | CHAIR / SPEAKER | STATUS |
|---|---|---|---|
| 08:50 ~ 17:00 | ★28th International Symposium of Yonsei Song-Dang Institute for Cancer Research★ |
|
종료 Closed |
| 08:50 ~ 08:55 | Opening Remarks |
Sun Young Rha, MD, PhD
(Director, Yonsei Song-Dang Institute for Cancer Research, Korea)
|
|
| 08:55 ~ 09:00 | Welcome Address |
Eun Jig Lee, MD, PhD
(Dean, Yonsei University College of Medicine, Korea)
|
|
| 09:00 ~ 10:10 | Session I : Translational Research in Precision Medicine |
Joo Hyuk Sohn, MD, PhD
(Yonsei Cancer Center, Korea)
Hyunki Kim, MD, PhD (Yonsei Cancer Center, Korea) |
|
| 09:00 ~ 09:20 | Next Generation ctDNA Research in Oncology |
Joo Hyuk Sohn, MD, PhD
(Yonsei Cancer Center, Korea)
|
|
| 09:20 ~ 09:45 | Microphysiological Systems-based 3D Co-culture Platform for Physiologically Relevant Cancer Therapeutic Models |
Sanghee Yoo, PhD
(Qureator, USA)
|
|
| 09:45 ~ 10:10 | Organoid Models of Tumor-intrinsic and Microenvironmental Cancer Progression |
Calvin J. Kuo, MD, PhD
(Stanford University, USA)
|
|
| 10:10 ~ 10:40 | Satellite Symposium |
Minkyu Jung, MD, PhD
(Yonsei Cancer Center, Korea)
|
|
| 10:10 ~ 10:40 | MSI-H as an Independent Entity in Gastric Cancer in the ICI Era |
Hisato Kawakami, MD, PhD
(Kindai University, Japan)
|
|
| 10:40 ~ 10:50 | Coffee Break |
|
|
| 10:50 ~ 12:00 | Session II : RNA/DNA-based Anti-cancer Strategy |
Hei-Cheul Jeung, MD, PhD
(Yonsei Cancer Center, Korea)
Choong-kun Lee, MD, PhD (Yonsei Cancer Center, Korea) |
|
| 10:50 ~ 11:15 | Immunomodulation in Pancreatic Cancer - The Role of Vaccines |
Kevin C. Soares, MD
(Memorial Sloan Kettering Cancer Center, USA)
|
|
| 11:15 ~ 11:40 | Translational Perspectives on Individualized Neoantigen Therapy mRNA-4157 |
Lakshmi Srinivasan, PhD
(Moderna Inc., USA)
|
|
| 11:40 ~ 12:00 | Cancer DNA Vaccine Development for Prostate Cancer |
June Young Park, PhD
(SL VAXIGEN Inc., Korea)
|
|
| 12:00 ~ 13:00 | Lunch |
|
|
| 13:00 ~ 14:25 | Session III : Data Science and Artificial Intelligence |
Sang Joon Shin, MD, PhD
(Yonsei Cancer Center, Korea)
Han Sang Kim, MD, PhD (Yonsei Cancer Center, Korea) |
|
| 13:00 ~ 13:25 | Patient-Specific Digital Twins for Risk-Aware Treatment of High-Grade Gliomas |
Anirban Chaudhuri, PhD
(The University of Texas at Austin, USA)
|
|
| 13:25 ~ 13:45 | Research Platform for Real-World, Medical Big Data in Medical Oncology |
Hyun-Ae Jung, MD, PhD
(Samsung Medical Center, Korea)
|
|
| 13:45 ~ 14:05 | AI in Drug Discovery: Current Practice and Challenges |
Sang Ok Song, PhD
(Standigm Inc., Korea)
|
|
| 14:05 ~ 14:25 | Development of a Continuous Metadata Supply Chain in Oncology with Dynamic Integraion of Multimodal Health Information |
Jee Suk Chang, MD, PhD
(Yonsei Cancer Center, Korea)
|
|
| 14:25 ~ 14:35 | Coffee Break |
|
|
| 14:35 ~ 15:20 | Professor Waun Ki Hong Memorial Lecture |
Jae Kyung Roh, MD, PhD
(Yonsei University College of Medicine, Korea)
|
|
| 14:35 ~ 14:40 | Congratulatory Remark |
Byung Soo Kim, MD, PhD
(Yonsei University College of Medicine, Korea)
|
|
| 14:40 ~ 15:20 | Choosing the Road Less Traveled by: “Dare to Push the Limit” |
Jin Soo Lee, MD, PhD
(Health Insurance Review & Assessment Service, Korea)
|
|
| 15:20 ~ 16:50 | Session IV : Novel Immunotherapeutics |
Joo Hang Kim, MD, PhD
(Cha University School of Medicine, Korea)
Kyong Hwa Park, MD, PhD (Korea University College of Medicine, Korea) |
|
| 15:20 ~ 15:45 | Targeting Advanced Prostate Cancer with STEAP1 Chimeric Antigen Receptor T cell and Tumor-localized IL-12 Immunotherapy |
John Kyung Lee, MD, PhD
(University of California, Los Angeles, USA)
|
|
| 15:45 ~ 16:05 | CLL-1 Targeting Heterodimeric T cell Engager, a Promising Tool for the Treatment of Patients with Acute Myeloid Leukemia |
Jonghwa Won, PhD
(ABL Bio Inc., Korea)
|
|
| 16:05 ~ 16:25 | Adjuvanting Cancer Vaccines in the Era of Combinatorial Tumor Immunotherapy |
Joon Haeng Rhee, PhD
(Chonnam National University Medical School, Korea)
|
|
| 16:25 ~ 16:50 | Targeting HPK1 to Extend Immunotherapy Benefit to More Cancer Patients |
Zhirong Shen, PhD
(BeiGene Inc., China)
|
|
| 16:50 ~ 17:00 | Closing Remarks |
Sun Young Rha, MD, PhD
(Director, Yonsei Song-Dang Institute for Cancer Research, Korea)
|